Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Urea inclusion compounds of enalapril maleate for the improvement of pharmaceutical characteristics
Journal of Pharmacy and Pharmacology, 11/01/07
Thakral, S., et al. - Urea is a well known adductor for linear organic compounds. In the present study, enalapril maleate, a substituted cyclic organic compound, was successfully included in urea together with a suitable rapidly adductible endocyte (RAE). Formation of the urea inclusion compound was confirmed by Fourier transform infrared spectroscopy, differential scanning calorimetry and X-ray diffraction
Related Articles
Are males with early breast cancer treated differently from females with early breast cancer in Australia and New Zealand
The Breast, 10/28/09
Relevance Score: 45%
Male gender as a favorable prognostic factor in pregnancies with enlarged nuchal translucency
Ultrasound in Obstetrics and Gynecology, 10/21/09
Relevance Score: 45%
High Prevalence of Metabolic Syndrome in First-Degree Male Relatives of Women with Polycystic Ovary Syndrome Is Related to High Rates of Obesity
Journal of Clinical Endocrinology and Metabolism, 10/21/09
Relevance Score: 45%
Male gender results in more severe lupus nephritis
Rheumatology International, 10/05/09
Relevance Score: 45%
Invasive papillary carcinoma of the male breast: Report of a rare case and review of the literature
Journal of Cancer Research and Therapeutics, 10/28/09
Relevance Score: 44%
Today in Cardiac/Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Valsartan and aliskiren (Valturna): Combination of an angiotensin receptor blocker with direct renin inhibitor approved for the treatment of hypertension
Formulary , 12/02/09
Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility
Vascular Health and Risk Management, 12/01/09
Assessment of the cardiac safety of fampridine-SR sustained-release tablets in a thorough QT/QTc evaluation at therapeutic and supratherapeutic doses in healthy individuals
Expert Opinion on Investigational Drugs, 12/01/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


